Immunome, Inc.'s (NASDAQ:IMNM) Institutional Investors Lost 6.0% Last Week but Have Benefitted From Longer-term Gains

Simply Wall StJul 22 07:00 ET

Immunome Insiders Added US$2.67m Of Stock To Their Holdings

Yahoo FinanceJul 19 09:39 ET

STALICLA Appoints Dr. Purnanand Sarma, PhD, as Chair of the Board of Directors

GlobeNewswireJul 9 07:00 ET

Express News | Immunome Appoints Phil Tsai as Chief Technical Officer

ReutersJun 27 08:00 ET

Evaluating Immunome: Insights From 4 Financial Analysts

BenzingaMay 31 09:00 ET

Immunome Initiated at Overweight by Piper Sandler

Dow JonesMay 31 06:09 ET